Ambri revenue, loss down
Thursday, 25 August, 2005
Ambri (ASX:ABI) saw a decrease in its revenue for the 2004-05 financial year of 27 per cent to $1 million (from $1.4 million in the previous year) but the company's loss was also down 22 per cent to $9 million.
Total expenses for 2004-05 were $10 million compared with $12.8 million in 2003-04, due to a reduction in headcount and R&D spending. The company halved its workforce from 76 to 32 people over the financial year, reducing employee expenses to $4.6 million.
Ambri had cash assets of $10.9 million at June 30, 2005.
Immune cell boost could enable lasting vaccine protection
A research team has found a promising new way to enhance the effectiveness of vaccines by tapping...
Genes influence when babies start walking
Genetics accounts for about a quarter of the differences in when children take their first steps,...
Novel glycopeptide antibiotic candidate shows promise
Researchers have discovered a new type of glycopeptide antibiotic known as saarvienin A, found to...
